ARATANA THERAPEUTICS, INC. (PETX) is a publicly traded company in the Unknown sector. Across all available filings, 30 corporate insiders have executed 197 transactions totaling $79.9M, demonstrating a bearish sentiment with -$55.8M in net insider flow. The most recent transaction on Jul 18, 2019 involved a transaction of 129,889 shares valued at $0.
No significant insider buying has been recorded for PETX in the recent period.
No significant insider selling has been recorded for PETX in the recent period.
Based on recent SEC filings, insider sentiment for PETX is bearish with an Insider Alignment Score of 15/100 and a net flow of -$55.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ARATANA THERAPEUTICS, INC. (PETX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 30 insiders are actively trading PETX stock, having executed 197 transactions in the past 90 days. The most active insider is Jay Lichter (Executive), who has made 4 transactions totaling $18.7M.
Get notified when executives and directors at PETX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 18, 2019 | C. Ayres John | Executive | Disposition | 129,889 | $N/A | $0 | |
| Jul 18, 2019 | A. Barbarosh Craig | Executive | Disposition | 4,500 | $N/A | $0 | |
| Jul 18, 2019 | L. Brinkley David | Executive | Disposition | 18,000 | $N/A | $0 | |
| Jul 18, 2019 | Heinen Ernst | Executive | Disposition | 170,617 | $N/A | $0 | |
| Jul 18, 2019 | Lynette Hellums Rhonda | Executive | Disposition | 51,424 | $N/A | $0 | |
| Jul 18, 2019 | O. Hockaday Irvine Jr | Executive | Disposition | 82,985 | $N/A | $0 | |
| Jul 18, 2019 | Raines Merilee | Executive | Disposition | 18,000 | $N/A | $0 | |
| Jul 18, 2019 | T. Ready Christopher | Executive | Disposition | 53,728 | $N/A | $0 | |
| Jul 18, 2019 | W. Robinson Lowell | Executive | Disposition | 4,500 | $N/A | $0 | |
| Jul 18, 2019 | P. Roche Robert Jr | Executive | Disposition | 18,000 | $N/A | $0 | |
| Jul 18, 2019 | A. Tooman Craig | Executive | Disposition | 307,501 | $N/A | $0 | |
| Jul 18, 2019 | John Vander Vort | Executive | Disposition | 43,000 | $N/A | $0 | |
| Jul 18, 2019 | L. Yarno Wendy | Executive | Disposition | 18,000 | $N/A | $0 | |
| Jul 18, 2019 | Llc Broadfin Capital, | Executive | Disposition | 7,258,135 | $N/A | $0 | |
| Jun 6, 2019 | A. Barbarosh Craig | Executive | Award | 4,500 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 75 | $67.9M | 78.9% |
Purchase(P) | 6 | $12.1M | 14.0% |
Exercise (Options)(X) | 1 | $5.5M | 6.4% |
Exercise(M) | 5 | $414.7K | 0.5% |
Payment(F) | 9 | $173.1K | 0.2% |
Disposition(D) | 14 | $0 | 0.0% |
Award(A) | 57 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Other(J) | 10 | $0 | 0.0% |
Conversion(C) | 18 | $0 | 0.0% |
Insider selling pressure at ARATANA THERAPEUTICS, INC. has increased, with 30 insiders executing 197 transactions across all time. Total sales of $67.9M significantly outpace purchases of $12.1M, resulting in a net outflow of $55.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.